Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Indust/Producer Dur Alphadex First Trust | FXR | Oct 31, 2024 | 75.49 | -1.11 |
Industrial Logistics Properties Trust | ILPT | Oct 31, 2024 | 3.54 | -3.15 |
Industrial Select Sector SPDR | XLI | Oct 31, 2024 | 133.83 | -1.15 |
Industrials ETF Vanguard | VIS | Oct 31, 2024 | 257.51 | -1.25 |
Infinera | INFN | Oct 31, 2024 | 6.72 | -0.30 |
InflaRx N.V | IFRX | Oct 31, 2024 | 1.55 | -1.27 |
Inflection Point Acquisition II | IPXX | Oct 31, 2024 | 10.76 | -0.23 |
Inflection Point Acquisition II Unit | IPXXU | Oct 31, 2024 | 10.86 | 0.00 |
Infobird | IFBD | Oct 31, 2024 | 1.94 | +2.11 |
Informatica | INFA | Oct 31, 2024 | 27.30 | +2.32 |
Information Services Group | III | Oct 31, 2024 | 3.07 | -2.23 |
Information Technology ETF Vanguard | VGT | Oct 31, 2024 | 582.30 | -3.32 |
Infosys ADR | INFY | Oct 31, 2024 | 20.91 | -0.99 |
InfuSystems | INFU | Oct 31, 2024 | 6.19 | +0.98 |
ING Group ADR | ING | Oct 31, 2024 | 16.95 | +0.95 |
Ingersoll Rand | IR | Oct 31, 2024 | 96.00 | -1.32 |
Ingevity | NGVT | Oct 31, 2024 | 41.79 | +0.34 |
Ingles Markets A | IMKTA | Oct 31, 2024 | 63.86 | -1.93 |
Ingram Micro Holding Corp | INGM | Oct 31, 2024 | 24.25 | 0.00 |
Ingredion | INGR | Oct 31, 2024 | 132.76 | -0.66 |
Inhibikase Therapeutics | IKT | Oct 31, 2024 | 2.53 | -8.66 |
Inhibrx Biosciences | INBX | Oct 31, 2024 | 16.03 | -1.60 |
InMed | INM | Oct 31, 2024 | 0.27 | -9.22 |
InMode | INMD | Oct 31, 2024 | 17.08 | -4.42 |
INmune Bio | INMB | Oct 31, 2024 | 5.85 | -1.68 |
Innate Pharma ADR | IPHA | Oct 31, 2024 | 1.89 | +3.33 |
Inno Holdings | INHD | Oct 31, 2024 | 4.04 | +4.66 |
Innodata | INOD | Oct 31, 2024 | 20.11 | -6.16 |
Innospec | IOSP | Oct 31, 2024 | 107.78 | -1.84 |
InnovAge | INNV | Oct 31, 2024 | 5.80 | -1.69 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.